Innocoll Pharmaceuticals Limited

NJ · United States · Reporting entity ID 100000961852

Total reported 2019–2025

$14.9M

#392 of 2,960 reporting companies — 0% of all reported industry payments

$368K in general payments across 3,777 records, plus $14.5M in research funding across 121 records.

How it breaks down

General payments $367,664

Research funding $14,503,800

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.